Human Genome Epidemiology Literature Finder
Records 1 - 8 (of 8 Records) |
Query Trace: Liver Neoplasms and TERT[original query] |
---|
The TERT promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer. Oncotarget 2015 Nov . Ko Eunkyong, Seo Hyun-Wook, Jung Eun Sun, Kim Baek-Hui, Jung Guhu |
Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity. Nature communications 2015 6 6120. Fujimoto Akihiro, Furuta Mayuko, Shiraishi Yuichi, Gotoh Kunihito, Kawakami Yoshiiku, Arihiro Koji, Nakamura Toru, Ueno Masaki, Ariizumi Shun-ichi, Nguyen Ha Hai, Shigemizu Daichi, Abe Tetsuo, Boroevich Keith A, Nakano Kaoru, Sasaki Aya, Kitada Rina, Maejima Kazihiro, Yamamoto Yujiro, Tanaka Hiroko, Shibuya Tetsuo, Shibata Tatsuhiro, Ojima Hidenori, Shimada Kazuaki, Hayami Shinya, Shigekawa Yoshinobu, Aikata Hiroshi, Ohdan Hideki, Marubashi Shigeru, Yamada Terumasa, Kubo Michiaki, Hirano Satoshi, Ishikawa Osamu, Yamamoto Masakazu, Yamaue Hiroki, Chayama Kazuaki, Miyano Satoru, Tsunoda Tatsuhiko, Nakagawa Hidewa |
Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations. World journal of gastroenterology 2015 Jan 21 (1): 311-7. Cevik Dilek, Yildiz Gokhan, Ozturk Mehm |
Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma. Hepatology (Baltimore, Md.) 2019 6 71 (1): 164-182. Nault Jean-Charles, Martin Yoann, Caruso Stefano, Hirsch Théo Z, Bayard Quentin, Calderaro Julien, Charpy Cecile, Copie-Bergman Christiane, Ziol Marianne, Bioulac-Sage Paulette, Couchy Gabrielle, Blanc Jean-Frédéric, Nahon Pierre, Amaddeo Giuliana, Ganne-Carrie Nathalie, Morcrette Guillaume, Chiche Laurence, Duvoux Christophe, Faivre Sandrine, Laurent Alexis, Imbeaud Sandrine, Rebouissou Sandra, Llovet Josep M, Seror Olivier, Letouzé Eric, Zucman-Rossi Jessi |
Clinical Significance of Telomerase Reverse-Transcriptase Promoter Mutations in Hepatocellular Carcinoma. Cancers 2021 Jul 13 (15): . Pezzuto Francesca, Izzo Francesco, De Luca Pasquale, Biffali Elio, Buonaguro Luigi, Tatangelo Fabiana, Buonaguro Franco Maria, Tornesello Maria Li |
Serum TERT C228T is an important predictor of non-viral liver cancer with fatty liver disease. Hepatology international 2022 3 16 (2): 412-422. Akuta Norio, Kawamura Yusuke, Suzuki Fumitaka, Kobayashi Mariko, Arase Yasuji, Saitoh Satoshi, Muraishi Nozomu, Fujiyama Shunichiro, Sezaki Hitomi, Hosaka Tetsuya, Kobayashi Masahiro, Suzuki Yoshiyuki, Ikeda Kenji, Kumada Hiromit |
Favorable Impact of Serum TERT C228T for Prognosis after Surgical Resection for Liver Cancer. Oncology 2023 8 1-15. Norio Akuta, Yusuke Kawamura, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Satoshi Saitoh, Mariko Kobayashi, Yasuji Arase, Kenji Ikeda, Yoshiyuki Suzuki, Hiromitsu Kumada, Fumitaka Suzu |
Integrated exome sequencing and microarray analyses detected genetic defects and underlying pathways of hepatocellular carcinoma. Cancer genetics 2023 7 276-277 30-35. Mei Ling Chong, James Knight, Gang Peng, Weizhen Ji, Hongyan Chai, Yufei Lu, Shengming Wu, Peining Li, Qiping |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: